Establishment the method of surveillance to find early pancreatic cancer for high risk individuals with familial Pancreatic Cancer or hereditary neoplastic syndrome

Establishment the method of surveillance to find early pancreatic cancer for high risk individuals with familial Pancreatic Cancer or hereditary neoplastic syndrome - DIAMOND study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000039779

Enrollment

400

Registered

2020-03-12

Start date

2019-04-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

EUS,MRCP

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Individuals more than 50y with two or more affected blood relatives, with at least one affected FDR. Individuals more than 50y with BRCA2 orCDKN2A or PALB2,mutation carriers with one affected FDR. Individuals more than 50y with STK11 or PRSS1 or p16 mutation.

Exclusion criteria

Exclusion criteria: total gastrectomy

Design outcomes

Primary

Measure	Time frame
the population of resecatble pancreatic cancer of pancreatic cancer	—

Countries

Japan

Contacts

Public ContactSUSUMU HIJIOKA

National Cancer Center Department of Hepatobiliary and Pancreatic Oncology

shijioka@ncc.go.jp+81-3-3542-2511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026